GlaxoSmithKline says senior executives in its China office appear to have broken the law amid a bribery scandal.
"We have zero tolerance for any behaviour of this nature,"
said Abbas Hussain, the UK pharmaceutical firm's Asia Pacific business
head. The acknowledgement comes as GSK says it is co-operating with
a Chinese investigation into alleged bribing of doctors to prescribe
the firm's drugs.
Meanwhile, rival AstraZeneca said one of its staff was also being questioned. GSK shares closed down 1.22% in London business.
More on this story here.
Post a Comment